Company: PFSA
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001213900-25-044417
Chunk: 363

Company: Profusa, Inc.
Filing Date: 2025-05-15
Form: 424B3
Chunk 363
---
 ) |
| Weighted average shares outstanding of New Profusa common stock – basic and diluted(4)     |     |               |           |   |     |              |           |   |     |                    | 33,002,012 |   |     |             | 32,949,853 |   |     |                    |       |   |     |             |       |   |

____________ (1)There were no cash dividends declared in the period presented. (2)Book value per share is calculated as (a) total permanent equity divided by (b) the total number of shares of New Profusa Common Stock outstanding classified in permanent equity.

197

(3)The equivalent per share data for Profusa is calculated by multiplying the combined pro forma per share data by the Exchange Ratio, as determined in accordance with the Merger Agreement. (4)The pro forma weighted average common shares outstanding include (a) outstanding convertible preferred stock of Profusa, which is entitled to the same per share merger consideration as Profusa common stock on an as converted to common stock basis, and (b) common stock of New Profusa issuable upon the conversion of junior convertible notes and senior convertible notes of Profusa. The following potential shares were excluded from the calculation of diluted net loss per share:

|                                                    |     |        As of 
 December 31, 
         2024 |     |        As of 
 December 31, 
         2023 |
|:---------------------------------------------------|:----|-------------:|:----|-------------:|
| Shares underlying NorthView’s outstanding warrants |     |   17,404,250 |     |   17,404,250 |
| Milestone Earnout Shares                           |     |    3,875,000 |     |    3,875,000 |
| Outstanding Profusa options                        |     |      855,508 |     |      937,395 |
| Sponsor Inducement Recoupment Shares               |     |            — |     |            — |
| Profusa Inducement Recoupment Shares               |     |            — |     |            — |
|                                                    |     |   22,134,758 |     |   22,216,645 |

•Shares underlying NorthView’s outstanding warrants are not included in the calculation of diluted net loss per share because these shares are contingently issuable, and the contingencies have not yet been met. •Milestone Earnout Shares are not included in the calculation